Clinical Research after COVID-19: Embracing a New Normal

The coronavirus disease 2019 (COVID-19) pandemic is a grave public health crisis, causing massive disruption to daily life. Dermatology clinical trials in psoriasis, atopic dermatitis, and hidradenitis have been suspended, terminated, or otherwise disrupted. Clinical investigators need to embrace a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelfand, Joel M., Hefele, Brooke E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466954/
https://www.ncbi.nlm.nih.gov/pubmed/32890628
http://dx.doi.org/10.1016/j.jid.2020.08.004
_version_ 1783577921246461952
author Gelfand, Joel M.
Hefele, Brooke E.
author_facet Gelfand, Joel M.
Hefele, Brooke E.
author_sort Gelfand, Joel M.
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic is a grave public health crisis, causing massive disruption to daily life. Dermatology clinical trials in psoriasis, atopic dermatitis, and hidradenitis have been suspended, terminated, or otherwise disrupted. Clinical investigators need to embrace a COVID-19 new normal and adjust research procedures to mitigate the risk of transmitting severe acute respiratory syndrome coronavirus 2 and depleting personal protective equipment while maintaining scientific rigor.
format Online
Article
Text
id pubmed-7466954
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.
record_format MEDLINE/PubMed
spelling pubmed-74669542020-09-02 Clinical Research after COVID-19: Embracing a New Normal Gelfand, Joel M. Hefele, Brooke E. J Invest Dermatol Commentary The coronavirus disease 2019 (COVID-19) pandemic is a grave public health crisis, causing massive disruption to daily life. Dermatology clinical trials in psoriasis, atopic dermatitis, and hidradenitis have been suspended, terminated, or otherwise disrupted. Clinical investigators need to embrace a COVID-19 new normal and adjust research procedures to mitigate the risk of transmitting severe acute respiratory syndrome coronavirus 2 and depleting personal protective equipment while maintaining scientific rigor. The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. 2021-03 2020-09-02 /pmc/articles/PMC7466954/ /pubmed/32890628 http://dx.doi.org/10.1016/j.jid.2020.08.004 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Gelfand, Joel M.
Hefele, Brooke E.
Clinical Research after COVID-19: Embracing a New Normal
title Clinical Research after COVID-19: Embracing a New Normal
title_full Clinical Research after COVID-19: Embracing a New Normal
title_fullStr Clinical Research after COVID-19: Embracing a New Normal
title_full_unstemmed Clinical Research after COVID-19: Embracing a New Normal
title_short Clinical Research after COVID-19: Embracing a New Normal
title_sort clinical research after covid-19: embracing a new normal
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466954/
https://www.ncbi.nlm.nih.gov/pubmed/32890628
http://dx.doi.org/10.1016/j.jid.2020.08.004
work_keys_str_mv AT gelfandjoelm clinicalresearchaftercovid19embracinganewnormal
AT hefelebrookee clinicalresearchaftercovid19embracinganewnormal

Ejemplares similares